Back to funds
View filing
Trails Edge Capital Partners, LP
hedge fundUpdated 27 days agoManaged by Trails Edge Capital Partners, Lp • Latest filing Q2 2026
Portfolio value
$629.9M
Q2 2026
Filings
3
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 3 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $404.7M |
| Q1 2026 | $436.5M |
| Q2 2026 | $629.9M |
Top holdings
35 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | L LBRX LB PHARMACEUTICALS INC | $49.4M | 1.52M | 7.85% | — |
| 2 | N NRIX NURIX THERAPEUTICS INC | $38.2M | 1.57M | 6.06% | — |
| 3 | I IMCR IMMUNOCORE HLDGS PLC | $33.8M | 1.06M | 5.36% | — |
| 4 | ? N/A FIRST TRACKS BIOTHERAPEUTICS | $30.5M | 1.51M | 4.84% | — |
| 5 | F FDMT 4D MOLECULAR THERAPEUTICS IN | $29.6M | 2.23M | 4.70% | — |
| 6 | B BMRN BIOMARIN PHARMACEUTICAL INC | $29.3M | 512.0K | 4.65% | — |
| 7 | D DSGN DESIGN THERAPEUTICS INC | $29M | 2.00M | 4.60% | — |
| 8 | X XENE XENON PHARMACEUTICALS INC | $26.6M | 440.0K | 4.22% | — |
| 9 | M MIRM MIRUM PHARMACEUTICALS INC | $26.1M | 223.3K | 4.15% | — |
| 10 | I INSM INSMED INC | $24.6M | 230.3K | 3.90% | — |
| 11 | C CYTK CYTOKINETICS INC | $24.5M | 288.1K | 3.90% | — |
| 12 | S SNDX SYNDAX PHARMACEUTICALS INC | $24.3M | 1.11M | 3.85% | — |
| 13 | N NGNE NEUROGENE INC | $22.5M | 714.9K | 3.57% | — |
| 14 | K KLRA KAILERA THERAPEUTICS INC | $21.7M | 984.8K | 3.44% | — |
| 15 | R RVMDW REVOLUTION MEDICINES INC | $21.7M | 115.8K | 3.44% | — |
| 16 | I IKT INHIBIKASE THERAPEUTICS INC | $18.4M | 9.05M | 2.92% | — |
| 17 | I INCY INCYTE CORP | $17.6M | 155.0K | 2.79% | — |
| 18 | A AVTX AVALO THERAPEUTICS INC | $16.5M | 891.9K | 2.62% | — |
| 19 | M MLTX MOONLAKE IMMUNOTHERAPEUTICS | $14.6M | 750.0K | 2.32% | — |
| 20 | F FTH FAETH THERAPEUTICS INC | $12.9M | 515.3K | 2.05% | — |